Fortis Hero 01 THE VISION AND CD46 PROMISE OF With novel, first-in-class therapeutics focused on CD46,
Fortis is transforming outcomes for patients with cancer. READ MORE Fortis Hero 03 TARGETED CD46 THERAPIES The proprietary Fortis approach directs precision-therapies
to CD46 proteins while sparing normal tissues. READ MORE

Home

PROPRIETARY, PRECISION
THERAPIES.

In the past, cancer treatment was a scorched-earth affair: zero distinguishing between healthy cells and their cancer counterparts. The proprietary Fortis approach directs precision-therapies to CD46 proteins — while sparing normal tissues.

We’ve brought together many of the smartest minds in technology and medicine to finally make treating tumor cells a simple task of identifying a target… and hitting it. No scattershot or shotgun approach, just total precision. And that can make all the difference.

NEXT-LEVEL
TREATMENT, AND THINKING.

PRECISION

At Fortis, we foster not only breakthrough science but absolute devotion to precision—and the technology that can deliver it.

PROOF

Our approach goes beyond a mere mission or set of beliefs. The proof: a higher-than-industry batting average for a first-class molecule.

PARTNERS

We rigorously screen partners, getting experiments—and results—absolutely right. Zero room for error.